Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 27 | 2025 | 775 | 3.440 |
Why?
|
| Pouchitis | 9 | 2025 | 56 | 2.250 |
Why?
|
| Crohn Disease | 14 | 2023 | 772 | 1.710 |
Why?
|
| Proctocolectomy, Restorative | 8 | 2025 | 105 | 1.640 |
Why?
|
| Colonic Pouches | 8 | 2025 | 86 | 1.530 |
Why?
|
| Inflammatory Bowel Diseases | 10 | 2025 | 609 | 1.130 |
Why?
|
| Ustekinumab | 2 | 2020 | 52 | 0.760 |
Why?
|
| Gastrointestinal Agents | 5 | 2025 | 179 | 0.640 |
Why?
|
| Capsule Endoscopes | 1 | 2017 | 5 | 0.550 |
Why?
|
| Antibodies, Monoclonal, Humanized | 5 | 2025 | 977 | 0.550 |
Why?
|
| Ileal Neoplasms | 1 | 2017 | 9 | 0.550 |
Why?
|
| Dysbiosis | 2 | 2016 | 89 | 0.530 |
Why?
|
| Transcriptome | 2 | 2025 | 700 | 0.530 |
Why?
|
| Foreign Bodies | 1 | 2017 | 65 | 0.510 |
Why?
|
| Intestinal Mucosa | 4 | 2019 | 815 | 0.430 |
Why?
|
| Microbiota | 3 | 2016 | 412 | 0.420 |
Why?
|
| Retrospective Studies | 23 | 2025 | 9679 | 0.410 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 246 | 0.410 |
Why?
|
| Remission Induction | 9 | 2025 | 763 | 0.410 |
Why?
|
| Intestines | 2 | 2016 | 426 | 0.380 |
Why?
|
| Colitis | 3 | 2021 | 253 | 0.380 |
Why?
|
| Colon | 6 | 2025 | 527 | 0.360 |
Why?
|
| Biological Products | 2 | 2025 | 171 | 0.340 |
Why?
|
| Autophagy | 1 | 2012 | 169 | 0.340 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 1191 | 0.330 |
Why?
|
| Adipose Tissue | 1 | 2012 | 267 | 0.330 |
Why?
|
| Ileum | 5 | 2025 | 168 | 0.310 |
Why?
|
| Humans | 43 | 2025 | 92304 | 0.310 |
Why?
|
| Treatment Outcome | 13 | 2025 | 8727 | 0.300 |
Why?
|
| Postoperative Complications | 7 | 2025 | 2450 | 0.300 |
Why?
|
| Adult | 21 | 2025 | 27535 | 0.290 |
Why?
|
| Cyclosporine | 2 | 2019 | 241 | 0.290 |
Why?
|
| Male | 24 | 2025 | 43924 | 0.260 |
Why?
|
| Inflammation | 6 | 2023 | 1025 | 0.260 |
Why?
|
| Interleukin-10 | 3 | 2017 | 160 | 0.260 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 74 | 0.260 |
Why?
|
| Immunosuppressive Agents | 3 | 2020 | 989 | 0.240 |
Why?
|
| Bacteroides fragilis | 2 | 2023 | 46 | 0.240 |
Why?
|
| Prospective Studies | 7 | 2025 | 4469 | 0.220 |
Why?
|
| Oxadiazoles | 1 | 2023 | 38 | 0.210 |
Why?
|
| Indans | 1 | 2023 | 35 | 0.210 |
Why?
|
| Female | 20 | 2025 | 47894 | 0.210 |
Why?
|
| Calcineurin Inhibitors | 2 | 2021 | 53 | 0.200 |
Why?
|
| Phenotype | 3 | 2025 | 2502 | 0.200 |
Why?
|
| Ulcer | 2 | 2022 | 38 | 0.200 |
Why?
|
| Tertiary Care Centers | 2 | 2025 | 121 | 0.200 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 192 | 0.200 |
Why?
|
| Enterocolitis | 1 | 2022 | 13 | 0.190 |
Why?
|
| Infliximab | 2 | 2020 | 161 | 0.190 |
Why?
|
| Opportunistic Infections | 1 | 2022 | 60 | 0.190 |
Why?
|
| Steroids | 2 | 2020 | 173 | 0.190 |
Why?
|
| Recurrence | 6 | 2021 | 1180 | 0.190 |
Why?
|
| Treatment Failure | 2 | 2019 | 288 | 0.190 |
Why?
|
| Piperidines | 2 | 2022 | 164 | 0.190 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 153 | 0.180 |
Why?
|
| Colonic Diseases | 1 | 2021 | 61 | 0.170 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 538 | 0.170 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2020 | 19 | 0.170 |
Why?
|
| Surgical Stomas | 1 | 2020 | 22 | 0.170 |
Why?
|
| Biosimilar Pharmaceuticals | 1 | 2020 | 25 | 0.170 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 105 | 0.160 |
Why?
|
| Aspirin | 1 | 2021 | 163 | 0.160 |
Why?
|
| Maintenance Chemotherapy | 1 | 2019 | 86 | 0.160 |
Why?
|
| Drug Substitution | 1 | 2019 | 27 | 0.160 |
Why?
|
| Drug Resistance | 1 | 2019 | 235 | 0.150 |
Why?
|
| Ileal Diseases | 1 | 2019 | 25 | 0.150 |
Why?
|
| Induction Chemotherapy | 1 | 2019 | 151 | 0.150 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 1920 | 0.150 |
Why?
|
| Middle Aged | 14 | 2025 | 27043 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2025 | 3773 | 0.150 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2019 | 24 | 0.150 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2019 | 160 | 0.140 |
Why?
|
| Pyrroles | 1 | 2019 | 171 | 0.140 |
Why?
|
| Histocytochemistry | 1 | 2017 | 131 | 0.140 |
Why?
|
| Secondary Prevention | 1 | 2018 | 172 | 0.130 |
Why?
|
| Radiography, Abdominal | 1 | 2017 | 68 | 0.130 |
Why?
|
| Microscopy | 1 | 2017 | 88 | 0.130 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2017 | 115 | 0.130 |
Why?
|
| Anastomosis, Surgical | 3 | 2025 | 280 | 0.130 |
Why?
|
| Bacteroides | 1 | 2016 | 35 | 0.130 |
Why?
|
| Gastrointestinal Motility | 1 | 2016 | 25 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2019 | 378 | 0.130 |
Why?
|
| Colectomy | 3 | 2025 | 179 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2019 | 965 | 0.120 |
Why?
|
| Clostridium Infections | 1 | 2018 | 125 | 0.120 |
Why?
|
| Genome, Bacterial | 1 | 2016 | 152 | 0.120 |
Why?
|
| Administration, Rectal | 1 | 2015 | 13 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 91 | 0.120 |
Why?
|
| Mucin-2 | 1 | 2015 | 12 | 0.120 |
Why?
|
| C-Reactive Protein | 3 | 2023 | 205 | 0.120 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 223 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 239 | 0.110 |
Why?
|
| Disease Progression | 2 | 2019 | 1504 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 324 | 0.110 |
Why?
|
| Young Adult | 6 | 2025 | 6628 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 808 | 0.110 |
Why?
|
| Metagenome | 1 | 2014 | 109 | 0.110 |
Why?
|
| Immune System | 1 | 2014 | 102 | 0.100 |
Why?
|
| Dexamethasone | 1 | 2015 | 347 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2022 | 2976 | 0.100 |
Why?
|
| Autophagy-Related Proteins | 1 | 2012 | 22 | 0.100 |
Why?
|
| Colonoscopy | 3 | 2019 | 300 | 0.100 |
Why?
|
| Beclin-1 | 1 | 2012 | 15 | 0.100 |
Why?
|
| Risk Factors | 5 | 2025 | 5705 | 0.100 |
Why?
|
| Endoscopy | 3 | 2021 | 359 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 203 | 0.090 |
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2023 | 49 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 185 | 0.090 |
Why?
|
| Genome | 1 | 2014 | 399 | 0.090 |
Why?
|
| Dialysis Solutions | 1 | 1990 | 7 | 0.090 |
Why?
|
| Fatty Acids, Volatile | 1 | 2011 | 36 | 0.090 |
Why?
|
| Lactates | 1 | 1990 | 37 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 79 | 0.090 |
Why?
|
| Butyrates | 1 | 2011 | 53 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2016 | 1392 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2012 | 680 | 0.080 |
Why?
|
| Biopsy | 1 | 2012 | 1194 | 0.070 |
Why?
|
| Postoperative Period | 2 | 2021 | 311 | 0.070 |
Why?
|
| Aged | 4 | 2020 | 19952 | 0.070 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 556 | 0.070 |
Why?
|
| Inpatients | 2 | 2021 | 331 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 868 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 1990 | 340 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2683 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2022 | 923 | 0.070 |
Why?
|
| Propensity Score | 2 | 2018 | 165 | 0.070 |
Why?
|
| Hemodynamics | 1 | 1990 | 757 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2037 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 581 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1242 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 575 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 708 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 2396 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1310 | 0.060 |
Why?
|
| Enterocytes | 1 | 2025 | 26 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 3375 | 0.060 |
Why?
|
| Prognosis | 2 | 2025 | 3872 | 0.060 |
Why?
|
| Amines | 1 | 2024 | 30 | 0.050 |
Why?
|
| Amides | 1 | 2024 | 56 | 0.050 |
Why?
|
| Bile | 1 | 2023 | 60 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1479 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2024 | 85 | 0.050 |
Why?
|
| Catalysis | 1 | 2024 | 210 | 0.050 |
Why?
|
| Amino Acids | 1 | 2024 | 256 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2023 | 175 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2022 | 86 | 0.050 |
Why?
|
| Osteonectin | 1 | 2022 | 22 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2017 | 2095 | 0.050 |
Why?
|
| Ostomy | 1 | 2020 | 15 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 5430 | 0.040 |
Why?
|
| Vitamin D | 1 | 2021 | 269 | 0.040 |
Why?
|
| Prednisolone | 1 | 2018 | 41 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 238 | 0.040 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2017 | 16 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2017 | 48 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2017 | 69 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 70 | 0.030 |
Why?
|
| Acute Disease | 1 | 2019 | 856 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 134 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 70 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 672 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 122 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 173 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2017 | 98 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 865 | 0.030 |
Why?
|
| Medical Records | 1 | 2017 | 122 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2017 | 151 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2016 | 84 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2018 | 196 | 0.030 |
Why?
|
| Metagenomics | 1 | 2016 | 96 | 0.030 |
Why?
|
| Illinois | 1 | 2017 | 503 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1902 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2015 | 147 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 452 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1142 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 334 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 247 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 374 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 259 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1399 | 0.030 |
Why?
|
| Hospitalization | 1 | 2019 | 926 | 0.030 |
Why?
|
| Chicago | 1 | 2018 | 1466 | 0.030 |
Why?
|
| Feces | 1 | 2015 | 349 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 3112 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1118 | 0.030 |
Why?
|
| Animals | 3 | 2017 | 28045 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 351 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2907 | 0.020 |
Why?
|
| Mice | 2 | 2016 | 12133 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2369 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 1775 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7303 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 1990 | 37 | 0.020 |
Why?
|
| Bicarbonates | 1 | 1990 | 58 | 0.020 |
Why?
|
| Acetates | 1 | 1990 | 69 | 0.020 |
Why?
|
| Phosphorus | 1 | 1990 | 117 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2448 | 0.020 |
Why?
|
| Lactic Acid | 1 | 1990 | 99 | 0.020 |
Why?
|
| Potassium | 1 | 1990 | 261 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 1052 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 3508 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1990 | 909 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1990 | 415 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 1990 | 1756 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 9491 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1724 | 0.010 |
Why?
|